Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| Opioid Risk Tool (ORT)× | Brief Addiction Monitor (BAM)× | |
|---|---|---|
| Valdkond | Sõltuvusmeditsiin | Sõltuvusmeditsiin |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 2005 | 2013 |
| Looja≠ | Webster, Webster | Cacciola, Alterman, Drapkin, Valadez |
| Tüüp | Self-report | Self-report |
| Algallikas≠ | Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Medicine, 6(6), 432–442. DOI ↗ | Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263. DOI ↗ |
| Rööpnimetused | ORT | BAM |
| Seotud | 4 | 4 |
| Kokkuvõte≠ | The ORT is a brief, 10-item self-report screening instrument designed to identify patients at elevated risk for opioid misuse, addiction, or aberrant drug-related behaviors prior to initiating opioid therapy. Developed by Webster and Webster in 2005, it stratifies patients into low, moderate, and high risk categories based on personal and family history of substance abuse, psychiatric comorbidity, and psychosocial factors. The ORT is widely used in pain management and primary care settings to guide shared decision-making and risk mitigation strategies when prescribing opioids. | The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care. |
| ScholarGateAndmestik ↗ |
|
|